SCAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SCAP monoclonal antibodies for studying Sterol Regulatory Element-Binding Protein (SREBP) cleavage-activating protein (SCAP). SCAP monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SCAP plays a fundamental role in regulating lipid metabolism and cholesterol homeostasis by functioning as a cellular sterol level sensor. Through modulation of SREBP activity, SCAP influences the expression of genes responsible for lipid synthesis and uptake. Research focused on SCAP continues to reveal important insights about metabolic disorders and potential therapeutic approaches. Understanding SCAP's molecular mechanisms has significant implications for developing new treatments targeting lipid-related diseases. Investigating SCAP's role in cellular metabolism provides valuable knowledge about how cells maintain cholesterol balance. Scientists studying SCAP can uncover new regulatory pathways in lipid homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cellular metabolism and human health.